These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 5681701)

  • 21. Cryoprecipitated factor 8 concentrate.
    Pool JG
    Bibl Haematol; 1970; 34():23-9. PubMed ID: 5436350
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preparatory procedures for obtaining antihemolytic globulin (factor VIII) by the cryoprecipitation method and its various properties].
    Lopaciuk S; Naleczyńska A; Klenowska Z; Daszyński J; Pawelski S
    Pol Tyg Lek; 1969 Jun; 24(22):826-9. PubMed ID: 5802316
    [No Abstract]   [Full Text] [Related]  

  • 23. A method for the production of AHG rich cryoprecipitates & their use in the management of bleeding episodes in haemophilia.
    Kwa SB; Chen YF
    Singapore Med J; 1968 Mar; 9(1):12-6. PubMed ID: 5659889
    [No Abstract]   [Full Text] [Related]  

  • 24. [Biological control of substitution therapy in hemophilia A].
    Lisichkov T
    Vutr Boles; 1972; 11(5):103-7. PubMed ID: 4680013
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemophilia].
    Krause W; Lasch HG
    Med Klin; 1969 Feb; 64(9):367-73. PubMed ID: 4890942
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemorrhagic episodes in hemophiliacs simulating abdominal surgical emergencies.
    Rabie ME; Al-Tayeb AR; Zafer MH; Sheikha AK
    Saudi Med J; 2004 Jan; 25(1):95-8. PubMed ID: 14758390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of the haemophiliac factor.
    Coutts AM
    Cent Afr J Med; 1997 Sep; 43(9):277-8. PubMed ID: 9509651
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of single factor deficiencies: a case study approach.
    Marques MB
    Clin Lab Sci; 2003; 16(2):120-2. PubMed ID: 12757193
    [No Abstract]   [Full Text] [Related]  

  • 29. The management of haemophilia.
    Rizza CR
    Practitioner; 1970 Jun; 204(224):763-72. PubMed ID: 5452203
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cellular immunology status in 5 hemophilic patients with inhibitors subjected to massive therapy with factor VIII concentrate].
    Aznar JA; Jorquera JI; González Molina A; Carbonell F; Trenor A; Sánchez Cuenca JM; de Andrés R
    Sangre (Barc); 1983; 28(5):663-4. PubMed ID: 6420915
    [No Abstract]   [Full Text] [Related]  

  • 31. Purification and clinical evaluation of a factor 8 concentrate.
    Johnson AJ; Karpatkin MH; Newman J
    Bibl Haematol; 1970; 34():30-9. PubMed ID: 5436351
    [No Abstract]   [Full Text] [Related]  

  • 32. Current status and trends in the treatment of hemophilic patients with inhibitors.
    Bloom AL
    Prog Clin Biol Res; 1981; 72():123-38. PubMed ID: 6801682
    [No Abstract]   [Full Text] [Related]  

  • 33. The management of hemophilia in Jakarta.
    Moeslichan S; Setianingsih I; Gatot D; Abdulsalam M; Munthe BG
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():274. PubMed ID: 7886596
    [No Abstract]   [Full Text] [Related]  

  • 34. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
    Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfusion support for haemophiliacs.
    Allain JP
    Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
    [No Abstract]   [Full Text] [Related]  

  • 36. New alternatives and strategies in the treatment of inhibitors.
    Hoyer LW
    Prog Clin Biol Res; 1984; 150():367-72. PubMed ID: 6431440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acquired hemophilia].
    Kantor R; Mayan H; Yaron D
    Harefuah; 2000 May; 138(10):860-4. PubMed ID: 10883255
    [No Abstract]   [Full Text] [Related]  

  • 38. [Odontological problems in patients with hemophilia].
    Giuliano L; Saracini A; Bertolotto C
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):145-58. PubMed ID: 6443703
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibitor development in a multitransfused patient with severe haemophilia A.
    van den Berg HM; Roosendaal G; Voorberg J; Mauser-Bunschoten EP
    Thromb Haemost; 1999 Jul; 82(1):151-2. PubMed ID: 10456472
    [No Abstract]   [Full Text] [Related]  

  • 40. [Present possibilities in the treatment of hemophilia with the available inhibitors].
    Haracić M; Kamhi J; Kurto J
    Med Arh; 1983; 37(4):175-80. PubMed ID: 6443876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.